Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy

Patients with glioblastoma multiforme (GBM) are profoundly immunosuppressed and may benefit from restoration of an antitumor immune response in combination with conventional radiation therapy and temozolomide (TMZ). The optimal strategies to evaluate clinically relevant immune responses to treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Fadul, Camilo E., Fisher, Jan L., Hampton, Thomas H., Lallana, Enrico C., Li, Zhongze, Gui, Jiang, Szczepiorkowski, Zbigniew M., Tosteson, Tor D., Rhodes, C. Harker, Wishart, Heather A., Lewis, Lionel D., Ernstoff, Marc S.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766324/
https://ncbi.nlm.nih.gov/pubmed/21499132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318215e300
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items